|
IVACAFTOR (N-Nitroso Ivacaftor)
|
|
0
|
375
|
March 22, 2024
|
|
Calculating Nitrosamine Limits (MasterClass)
|
|
4
|
2018
|
March 19, 2024
|
|
N-nitroso cyclamate
|
|
9
|
760
|
March 15, 2024
|
|
NDMA evaluation in battery of in vivo Genotoxicity assays once again leading to AI much greater than 96 ng/day
|
|
0
|
327
|
March 13, 2024
|
|
Open-Access Software for Chemical Read-Across
|
|
0
|
429
|
March 12, 2024
|
|
LOQ for small nitrosamines
|
|
1
|
455
|
March 11, 2024
|
|
AI limit for N-Nitroso Losartan
|
|
4
|
780
|
March 9, 2024
|
|
Ribociclib Succinate NDSRIs limit clarification related
|
|
6
|
1433
|
March 5, 2024
|
|
AI value for Nitroso Folic acid
|
|
4
|
1817
|
February 26, 2024
|
|
Risk characterization of N-nitrosodimethylamine in pharmaceuticals -Pub
|
|
6
|
737
|
February 16, 2024
|
|
Developing and validating read-across workflows that enable decision making for toxicity and potency: Case studies with N-nitrosamines -Pub
|
|
4
|
478
|
February 14, 2024
|
|
Nitrosamines Severity (impact) - a quantitative model proposal?
|
|
3
|
1085
|
February 12, 2024
|
|
Defining nitrosamine acceptable intake based on technical feasibible limit rather than CPCA
|
|
6
|
532
|
February 11, 2024
|
|
N- nitroso Nitazoxanide
|
|
1
|
580
|
February 8, 2024
|
|
TGA (Australia) :australia: Updates Published Acceptable Intakes
|
|
3
|
983
|
February 7, 2024
|
|
Aromatic nitrogen "Is it possible for aromatic nitrogen to convert nitrosamine?"- Indole
|
|
10
|
2619
|
February 2, 2024
|
|
Nitrosamine Impurities in Topical Drug Product
|
|
3
|
660
|
February 3, 2024
|
|
N-nitroso Vonoprazan AI 96 ng/day- FDA
|
|
5
|
4195
|
January 29, 2024
|
|
Limit for NDSRI
|
|
3
|
1522
|
January 29, 2024
|
|
Updated EMA-Acceptable intakes (AIs) established for N-nitrosamines
|
|
20
|
6603
|
January 29, 2024
|
|
How to identify NDSRI for an API
|
|
5
|
871
|
January 24, 2024
|
|
The comprehensive prediction of carcinogenic potency and tumorigenic dose (TD50) for two problematic N-nitrosamines in food: NMAMPA and NMAMBA using toxicology in silico methods -Pub
|
|
0
|
289
|
January 23, 2024
|
|
A quick (dumb) question
|
|
10
|
1415
|
January 22, 2024
|
|
Confidence score calculation for the carcinogenic potency categorization approach (CPCA) predictions for N-nitrosamines
|
|
5
|
1329
|
January 11, 2024
|
|
Nitroso-melatonin
|
|
3
|
1011
|
January 4, 2024
|
|
Calculation of allowable limit in drug product with two API's
|
|
3
|
915
|
January 4, 2024
|
|
AI limit for N-nitroso betahistine?
|
|
26
|
4365
|
January 4, 2024
|
|
NDSRI in metronidazole
|
|
1
|
943
|
December 28, 2023
|
|
What should be the AI for N-Nitrosamines where CPCA doesn't apply (e.g. N-Nitroso Pyrrole Analogues where alpha carbon directly double bonded to hetero atom)?
|
|
1
|
941
|
December 27, 2023
|
|
Calculation of Nitrosamines AI not covered by CPCA
|
|
3
|
1117
|
December 20, 2023
|